Agenus Provides Update on Balstilimab Development
Go back to Agenus Provides Update on Balstilimab Development| AGENUS (NASDAQ: AGEN) | Delayed: 2.95 +0.03 (1.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.92 | 52 Week High | $7.49 | |||
| Open | $2.92 | 52 Week Low | $2.61 | |||
| Day High | $3.05 | P/E | N/A | |||
| Day Low | $2.92 | EPS | $-1.10 | |||
| Volume | 413,949 | |||||
